Full Press Release Details
Accelr8 Announces NASDAQ Capital Market
Common Stock to begin trading on NASDAQ
under the symbol "AXDX" on December 26, 2012
DENVER, Colo., December 12, 2012 - Accelr8 Technology
Corporation (NYSE MKT: AXK) announced today that its common stock has been approved by The NASDAQ Stock Market, LLC for listing
on the NASDAQ Capital Market. The Company expects to commence trading on NASDAQ under the ticker symbol "AXDX" on Wednesday,
December 26, 2012. Until such date, the Company's common stock will continue to be traded on NYSE MKT (formerly known as
NYSE Amex) under its current ticker symbol, "AXK".
Accelr8 Technology Corporation (www.accelr8.com) Accelr8 Technology
Corporation is focused on developing and commercializing innovative instrumentation for the rapid identification and antibiotic
susceptibility testing of infectious pathogens. The Company's BACcelTM platform utilizes a proprietary culture-free
process with both genomic and phenotypic detection technologies that decrease time to result while maintaining high sensitivity
Disclaimer Regarding Forward-Looking Statements
Certain statements in this news release may be "forward-looking
statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Statements regarding future prospects and developments are based upon current expectations and
involve certain risks and uncertainties that could cause actual results and developments to differ materially from the forward-looking
statement, including those detailed in the Company's filings with the SEC. The Company does not undertake an obligation
to publicly update or revise any forward-looking statements, whether as a result of new information or future events.